Skip to main content

Closed

ANTX: AN2 Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-45.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio15.73×

AN2 Therapeutics, Inc.

ANTXNASDAQ Global Select·USD·Closed

AN2 Therapeutics, Inc.

ANTXNASDAQ·USD·Closed

$5.35

+0.38%

$5.35

+$0.02 (0.38%)

52W Range

74thpctl

Volume

0.84×avg

Mkt Cap

192.69MUSD

P/E

-4.9TTM

Div Yield

–ann

52W Range

74thpctl

Volume

0.84×avg

Market Cap

192.69MUSD

P/E Ratio

-4.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings